4.8 Article

Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19

Related references

Note: Only part of the references are listed.
News Item Medicine, General & Internal

Nature does things well

[Anonymous]

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2022)

Article Medicine, General & Internal

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

Nicole Wolter et al.

Summary: According to data analysis from South Africa, individuals infected with the omicron variant have a lower likelihood of hospitalization compared to those infected with non-omicron variants. Furthermore, individuals infected with the omicron variant have a lower odds of severe disease compared to individuals infected with the earlier delta variant.

LANCET (2022)

Article Multidisciplinary Sciences

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

Raquel Viana et al.

Summary: The SARS-CoV-2 epidemic in southern Africa has experienced three distinct waves, driven by different variants. The recently identified Omicron variant has rapidly spread in South Africa and to numerous countries, raising global concern.

NATURE (2022)

Article Multidisciplinary Sciences

Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation

Akatsuki Saito et al.

Summary: During the COVID-19 pandemic, the B.1.617.2/Delta variant has been found to be highly fusogenic and more pathogenic in infected hamsters compared to prototypic SARS-CoV-2. The P681R mutation in the spike protein of this variant enhances viral fusogenicity and pathogenicity.

NATURE (2022)

Letter Critical Care Medicine

Omicron Variant in the Critical Care Units of the Paris Metropolitan Area: The Reality Research Group

Antoine Vieillard-Baron et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Medicine, General & Internal

Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments A Retrospective Cohort Study

Donia Bouzid et al.

Summary: This study compares baseline characteristics and in-hospital outcomes of patients with SARS-CoV-2 infection with the Delta variant versus the Omicron variant in the emergency department. The results show that patients infected with the Omicron variant were younger, had a lower rate of obesity, were more vaccinated, had a lower rate of dyspnea, and had a higher rate of discharge home from the ED. Compared with Delta, Omicron infection was independently associated with a lower risk for ICU admission, mechanical ventilation, and in-hospital mortality.

ANNALS OF INTERNAL MEDICINE (2022)

Article Medicine, General & Internal

Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study

Cristina Menni et al.

Summary: This study investigated the differences in symptom prevalence, risk of hospital admission, and symptom duration between omicron and delta variants of the SARS-CoV-2 virus. The study found that loss of smell was less common in omicron infections, sore throat was more common, and the rate of hospital admission was lower.

LANCET (2022)

Article Biochemistry & Molecular Biology

Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California

Joseph A. Lewnard et al.

Summary: Comparison of outcomes of SARS-CoV-2 Delta and Omicron infections reveals reduced severity of Omicron infections, especially in unvaccinated individuals. There is no differential risk of severe outcomes between subvariants BA.1 and BA.2. Continual assessment of clinical outcomes associated with SARS-CoV-2 variants is crucial for medical interventions and healthcare resource management.

NATURE MEDICINE (2022)

Article Biochemistry & Molecular Biology

Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa

Houriiyah Tegally et al.

Summary: The genomic characterization of the SARS-CoV-2 Omicron lineages BA.4 and BA.5, responsible for the fifth wave of the COVID-19 pandemic in South Africa, reveals their continued viral diversification and sheds light on the potential mechanisms that allow these new lineages to outcompete their predecessors. These new lineages, BA.4 and BA.5, share identical spike proteins with BA.2 but have certain differences such as the presence of the 69-70 deletion, L452R, F486V, and the wild-type amino acid at Q493. They can be identified by the S-gene target failure, a proxy marker associated with the 69-70 deletion. BA.4 and BA.5 have rapidly replaced BA.2 and have become the dominant lineages in South Africa.

NATURE MEDICINE (2022)

Editorial Material Medicine, General & Internal

Covid-19: What we know about the BA.4 and BA.5 omicron variants

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2022)

Article Biochemistry & Molecular Biology

Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages

Shuai Xia et al.

Summary: The Omicron variant and its sublineages exhibit increased transmissibility and immune escape, leading to numerous infections and breakthrough cases.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Infectious Diseases

Different mutations in SARS-CoV-2 associate with severe and mild outcome

Adam Nagy et al.

Summary: The study found a correlation between protein-level mutations in the SARS-CoV-2 virus and clinical outcomes, with some mutations associated with severe disease.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)

News Item Multidisciplinary Sciences

HOW SEVERE ARE OMICRON INFECTIONS?

Heidi Ledford

Summary: As cases of the coronavirus variant continue to spread, researchers are eagerly awaiting crucial data on the severity of the disease to assist countries in planning their response.

NATURE (2021)

Article Microbiology

Emerging Severe Acute Respiratory Syndrome Coronavirus 2 Mutation Hotspots Associated With Clinical Outcomes and Transmission

Xianwu Pang et al.

Summary: Mutations in the SARS-CoV-2 genome are directly associated with clinical outcomes and pandemic, with mutations more likely to occur in mild and severe cases. Mutations associated with asymptomatic cases are mainly found in open reading frame 1ab (ORF1ab) and N genes, while mutations in mild and severe cases are more prevalent.

FRONTIERS IN MICROBIOLOGY (2021)

Article Infectious Diseases

A minimal common outcome measure set for COVID-19 clinical research

J. C. Marshall et al.

LANCET INFECTIOUS DISEASES (2020)

Article Public, Environmental & Occupational Health

ORF3a mutation associated with higher mortality rate in SARS-CoV-2 infection

Parinita Majumdar et al.

EPIDEMIOLOGY AND INFECTION (2020)

Article Public, Environmental & Occupational Health

Numero: a statistical framework to define multivariable subgroups in complex population-based datasets

Song Gao et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2019)

Review Statistics & Probability

Distance-based clustering of mixed data

Michel van de Velden et al.

WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL STATISTICS (2019)

Article Medicine, General & Internal

A global clinical measure of fitness and frailty in elderly people

K Rockwood et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)

Article Computer Science, Artificial Intelligence

How to make large self-organizing maps for nonvectorial data

T Kohonen et al.

NEURAL NETWORKS (2002)